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Summary
Leptin, an adipocyte-derived hormone, acts directly
on the brain to control food intake and energy expen-
diture. An important question is the identity of first-or-
der neurons initiating leptin’s anti-obesity effects. A
widely held view is that most, if not all, of leptin’s ef-
fects are mediated by neurons located in the arcuate
nucleus of the hypothalamus. However, leptin recep-
tors (LEPRs) are expressed in other sites as well, in-
cluding the ventromedial hypothalamus (VMH). The
possible role of leptin acting in ‘‘nonarcuate’’ sites
has largely been ignored. In the present study, we
show that leptin depolarizes and increases the firing
rate of steroidogenic factor-1 (SF1)-positive neurons
in the VMH. We also show, by generating mice that
lack LEPRs on SF1-positive neurons, that leptin action
at this site plays an important role in reducing body
weight and, of note, in resisting diet-induced obesity.
These results reveal a critical role for leptin action on
VMH neurons.
Introduction
Defects in leptin signaling cause severe obesity in ro-
dents and humans. Mice lacking leptin (Lepob/ob mice)
or its receptor (Leprdb/db mice) are obese and diabetic
(Bray and York, 1979; Coleman, 1978; Lee et al., 1996;
Tartaglia et al., 1995; Zhang et al., 1994). It is well estab-
lished that leptin acts via the brain to cause its weight re-
ducing actions (Halaas et al., 1997). Central nervous sys-
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5 These authors contributed equally to this work.tem (CNS)-specific deletion of LEPRs results in marked
obesity (Cohen et al., 2001), whereas transgenic, brain-
specific reconstitution of LEPRs in leptin-receptor-defi-
cient Leprdb/db mice ameliorates obesity (Kowalski et al.,
2001). Leptin receptors (LEPRs) are abundantly ex-
pressed in several different sites within the hypothala-
mus, an area known to be important in regulating body
weight. These sites include the arcuate (ARC), the dor-
somedial nucleus of the hypothalamus (DMH), the lateral
hypothalamic area (LHA), and the ventromedial hypo-
thalamic nucleus (VMH) (Elmquist et al., 1998; Elmquist
et al., 1997; Fei et al., 1997; Mercer et al., 1996; Schwartz
et al., 1996). The relative importance of leptin action at
these different sites is unknown.
Most models of leptin action in the brain give primary
importance to neurons in the ARC. The ARC contains
two populations of first-order, leptin-responsive neu-
rons, specifically NPY/AGRP and POMC/CART neurons
(Schwartz and Porte, 2005). NPY/AGRP neurons pro-
mote weight gain and are inhibited by leptin (Cowley
et al., 2001; van den Top et al., 2004), whereas POMC/
CART neurons promote weight loss and are activated
by leptin (Cowley et al., 2001; Elias et al., 1999). The
widely held view of the importance of the ARC is based
largely on indirect evidence, the essence of which is
summarized here: (1) NPY/AGRP neurons and POMC/
CART neurons express LEPRs; (2) neuropeptides that
can affect energy homeostasis are released by these
neurons (orexigenic neuropeptides, NPY and AGRP,
from NPY/AGRP neurons and the anorexigenic neuro-
peptide, aMSH, from POMC/CART neurons); (3) defi-
ciency of leptin or LEPRs causes changes in neuropep-
tide gene expression consistent with observed effects
on body weight; and (4) leptin has acute electrophysio-
logic effects on these neurons consistent with its effects
on body weight (Bjorbaek and Kahn, 2004; Jobst et al.,
2004; Kalra et al., 1999; Schwartz and Porte, 2005).
Such compelling, indirect evidence supporting a role
for leptin action in the ARC, in the relative absence of ev-
idence implicating a role for leptin action in other sites,
has led to the assumption that most, if not all, of leptin’s
important effects on energy homeostasis are mediated
by actions on NPY/AGRP neurons and POMC/CART
neurons in the arcuate nucleus of the hypothalamus.
Recently, we used Cre/lox conditional gene-knockout
technology to generate mice lacking LEPRs on POMC
neurons (Balthasar et al., 2004). Deletion of LEPRs on
POMC neurons resulted in mild obesity. This is in stark
contrast to the massive obesity observed in Leprdb/db
mice, which lack LEPRs everywhere. From these results,
we speculate that neurons in locations other than the
ARC also contribute to the anti-obesity actions of leptin.
One potentially important site for leptin action is the
VMH. Evidence implicating this region includes the fol-
lowing: (1) destructive lesions of the VMH produce mas-
sive obesity (Hetherington and Ranson, 1940), although
the specificity of such lesions has been called into ques-
tion (Gold, 1973); (2) gene-knockout mice deficient in
steroidogenic factor-1 (SF1), a transcription factor ex-
pressed in the VMH, have abnormal VMH development
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192Figure 1. Generation and Validation of Sf1-Cre BAC-Transgenic Mice
(A) Mice expressing Cre recombinase under the control of the Sf1 promoter were generated by inserting a Cre recombinase expression cassette
into a BAC genomic clone containing Sf1.
(B) Immunohistochemical staining for GFP in an Sf1-Cre, lox-GFP mouse (Sf1-Cre mouse X Z/EG reporter mouse). Orange-brown stain repre-
sents Cre activity. Scale bar = 100 mm.
(C) In situ hybridization for endogenous Sf1-mRNA in a wild-type mouse with a 35S-labeled riboprobe. Scale bar = 100 mm.
(D) Colocalization of Cre activity (as indicated by eGFP-IR [orange-brown stain]) with Sf-1 mRNA (as indicated by overlying black silver granules)
in an Sf1-Cre, lox-GFP reporter mouse. Arrows represent double labeled cells; scale bar = 10 mm.(Dellovade et al., 2000) and are obese (Majdic et al.,
2002); (3) the expression of brain-derived neurotrophic
factor (BDNF), the deficiency of which causes obesity
(Rios et al., 2001), is nutritionally regulated in the VMH
(Xu et al., 2003); and (4) LEPRs are abundantly ex-
pressed in the VMH (Elmquist et al., 1998), and these
LEPRs are readily engaged by peripheral leptin, as evi-
denced by induction of c-fos immunoreactivity and
SOCS-3 mRNA (Bjorbaek et al., 1999; Elmquist et al.,
1997). These findings raise the possibility that leptin ac-
tion on VMH neurons plays an important role in regulat-
ing energy homeostasis. To test the hypothesis that
LEPRs on SF1 neurons mediate important actions of
leptin, we generated mice lacking LEPRs exclusively
on SF1 neurons. Phenotypic and electrophysiologic
analyses of these mice permit us to directly test the im-
portance of leptin action on SF1 neurons.
Results
Generation and Characterization of Sf1-Cre Mice
Sf1-Cre transgenic mice expressing Cre recombinase
(Cre) in SF1 neurons were generated by engineering an
Sf1 (approved mouse gene name, Nr5a1) bacterial artifi-
cial chromosome (BAC) such that Cre expression is
driven by Sf1 regulatory elements (Figure 1A). Several
lines of Sf1-Cre transgenic mice were generated. To as-
sess whether functional Cre protein was restricted to
areas known to express SF1, we crossed all lines of
Sf1-Cre mice with Z/EG Cre reporter mice (Tg
[ACTBBgeo/GFP] 21Lbe stock# 003920; http://www.
jaxmice.jax.org/). Z/EG Cre reporter mice express en-
hanced green fluorescent protein (eGFP) after Cre-me-
diated excision of a loxP-flanked lacZ gene (Novak
et al., 2000). Lines of double-transgenic mice (hence-
forth referred to as Sf1-Cre, lox-GFP mice) were exam-ined for eGFP expression in the CNS by immunohisto-
chemical detection of GFP protein. Two lines (line 2
and 7) expressed Cre activity in a pattern mimicking
that of Sf1 mRNA expression (Figures 1B and 1C). In
the case of line 2, Cre activity was also noted in the ce-
rebral cortex and in a few scattered cells in the caudal
brainstem. Notably, LEPRs are not expressed in these
neurons; therefore, Cre expression in these sites will
be without effect. Cre activity was also observed in the
pituitary, gonads and adrenals, tissues known to ex-
press SF1 (data not shown).
Colocalization for Cre activity (immunohistochemical
detection of GFP) and Sf1 mRNA expression (in situ hy-
bridization) was performed to test whether Cre recombi-
nase activity was restricted to SF1 neurons in the VMH
(Figure 1D). A neuron was considered positive for Cre
activity if the cell body and nucleus was clearly DAB la-
beled (orange-brown stain in Figure 1D). A GFP-positive
neuron was considered ‘‘SF1 positive’’ if its cell body
was decorated with at least ten black silver grains (33
above background). We identified 1000 VMH neurons
that were GFP positive and scored these as either
‘‘SF1 positive’’ or ‘‘SF1 negative’’ in two series of brain
sections from two Sf1-Cre, lox-GFP mice. Of these
1000 GFP-positive neurons, greater than 99% were
SF1 positive. Thus, essentially all VMH neurons express-
ing Cre activity are SF1-positive neurons.
Generation of Mice Lacking Leptin Receptors
in SF1 Neurons
We generated mice lacking LEPRs on SF1 neurons by
first crossing mice homozygous for a loxP-modified
Lepr allele (Leprflox/flox mice) (Balthasar et al., 2004;
McMinn et al., 2004) with Sf1-Cre mice. Leprflox/wt off-
spring from this cross were then bred with Sf1-Cre,
Leprflox/wt littermates to generate Sf1-Cre, Leprflox/flox
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193Figure 2. Leptin-Induced pSTAT3 Activation in Leprflox/flox and Sf1-Cre, Leprflox/flox Mice
(A–D) pSTAT3 immunohistochemistry from representative saline-injected Leprflox/flox and Sf1-Cre, Leprflox/flox mice (A and B, respectively) and
representative leptin-injected Leprflox/flox and Sf1-Cre, Leprflox/flox mice (C and D, respectively). Scale bar = 100 mm.
(E) The graph represents the number of pSTAT3-positive neurons in a single series of sections through the VMH. n = 3 per group; 2–4 VMH-con-
taining sections were counted bilaterally for each animal. Data are represented as the average number of leptin-induced pSTAT3 positive cells
per section. Double asterisk = p < 0.01 versus Leprflox/flox.
(F–K) Colocalization of leptin-induced pSTAT3 and GFP in the dorsomedial VMH (dmVMH) in an Sf1-Cre, lox-GFP Leprwt/wt control and Sf1-Cre,
lox-GFP Leprflox/flox mouse. (F and I) SF1-positive neurons in the dmVMH in an Sf1-Cre, lox-GFP Leprwt/wt control (F) and an Sf1-Cre, lox-GFP
Leprflox/flox mouse (I). (G and J) Leptin-induced pSTAT3-positive neurons in the dmVMH in an Sf1-Cre, lox-GFP Leprwt/wt control (G) and an
Sf1-Cre, lox-GFP Leprflox/flox mouse (G). (H and K) Colocalization of leptin-induced pSTAT3 and GFP in the dmVMH in an Sf1-Cre, lox-GFP
Leprwt/wt control (H) and Sf1-Cre, lox-GFP Leprflox/flox mouse (K). Scale bar = 20 mm. Green = GFP-positive neuron; red = pSTAT3-positive neuron;
orange = GFP + pSTAT3 double-labeled neuron. Arrows in (F), (G), and (H) indicate the neurons, through all three views, that are doubly positive
for both GFP and pSTAT3.mice. The loxP modified Lepr allele was constructed
such that loxP sequences flank exon 17 and 170 of the
Lepr allele. In the presence of Cre recombinase, a trun-
cated nonfunctional LEPR-b protein is generated
(LeprD17 allele). Indeed, mice homozygous for the de-
leted LeprD17 allele are phenotypically identical to
Leprdb/db mice (Balthasar et al., 2004; McMinn et al.,
2004).
To validate the loss of functional LEPRs exclusively on
SF1 neurons in mice that are Sf1-Cre transgenic and ho-
mozygous for the loxP-modified Lepr allele (Sf1-Cre,
Leprflox/flox mice), we acutely injected leptin and per-
formed immunohistochemistry (IHCC) for phosphory-
lated signal transducer and activator of transcription-3
(pSTAT3). Previous studies have shown that leptin bind-ing to its receptor leads to induction of pSTAT3 in areas
in the brain where LEPRs are present such as the hypo-
thalamus and brainstem (Munzberg et al., 2003). There-
fore, pSTAT3 induction can be used as a functional as-
say for leptin activated cells. A single intraperitonal
injection of leptin induced the expected pattern of
pSTAT3 activation in Leprflox/flox mice, including promi-
nent induction in the ARC, DMH, and the VMH (Fig-
ure 2C). Notably, leptin’s ability to induce pSTAT3 in
VMH neurons of Sf1-Cre, Leprflox/flox mice was markedly
reduced (Figure 2D). Quantification of VMH pSTAT3
leptin-responsive cells in Leprflox/flox and Sf1-Cre,
Leprflox/flox mice revealed an w80% reduction in the
number of leptin-responsive cells in Sf1-Cre,
Leprflox/flox mice (Figure 2E).
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194Figure 3. Electrophysiologic Recordings of
VMH Neurons
(A) Leptin depolarized SF1 neurons and in-
creased the frequency of action potentials
in Sf1-Cre, lox-GFP, Leprwt/wt mice. (A)
shows a whole-cell recording trace represen-
tative of 14 out of 17 total recordings made on
GFP-positive neurons fromSf1-Cre, lox-GFP,
Leprwt/wt mice. The bar above the trace indi-
cates drug exposure time. The dashed line in-
dicates the baseline membrane potential.
(B) Leptin did not alter membrane potential or
firing rate of SF1 neurons from Sf1-Cre, lox-
GFP, Leprflox/flox mice. (B) shows a represen-
tative trace of 16 out of 16 total recordings
made on GFP-positive neurons from Sf1-
Cre, lox GFP, Leprflox/flox mice.
(C) Statistical summary of leptin effects on
Sf1-Cre, lox-GFP, Leprwt/wt (wt) and Sf1-
Cre, lox-GFP, Leprflox/flox (KO) SF1 neurons.
Data are represented as mean6 SEM. Leptin
significantly induced membrane depolariza-
tion in wt (left, asterisk = p < 0.0003, n = 17),
whereas no change was seen in KO neurons
(n = 16). In addition, wt neurons had in-
creased firing rate versus no change in KO
cells (right, asterisk = p < 0.003, n = 17, wt,
n = 16 KO).
(D) Table summarizing responses of SF1 and
non-SF1 neurons to leptin in Sf1-Cre, lox-
GFP, Leprwt/wt mice. See Experimental Pro-
cedures for criteria used to define ‘‘Activa-
tion,’’ ‘‘Inhibition,’’ and ‘‘No response.’’
(E) Leptin hyperpolarized some GFP-negative
VMH neurons. (E) shows a whole-cell record-
ing trace representative of eight recordings
made on GFP-negative neurons from Sf1-
Cre, lox-GFP, Leprwt/wt mice.pSTAT3 induction by leptin persisted in some VMH
neurons of Sf1-Cre, Leprflox/flox mice. The majority of
these neurons were located in the central subdivision
of the VMH (cVMH) (Figure 2D) (Canteras et al., 1994).
This is in contrast with the dorsomedial subdivision of
the VMH (dmVMH), where nearly all pSTAT induction
was lost in Sf1-Cre, Leprflox/flox mice (Figure 2D). The
persistence of pSTAT3 induction in some VMH neurons
of Sf1-Cre, Leprflox/flox mice could be explained by either
incomplete inactivation of LEPRs on SF1-positive neu-
rons or, alternatively, by expression of LEPRs on SF1-
negative neurons. Unfortunately, antibodies suitable
for SF1-protein detection in brain sections are unavail-
able. As an alternative approach toward addressing
this issue, we performed double IHCC studies for
Cre-dependent eGFP (used to indirectly detect SF1 neu-
rons) and leptin-induced pSTAT3 in Sf1-Cre, lox-GFP,
Leprwt/wt mice and in Sf1-Cre, lox-GFP, Leprflox/flox
mice. As can be seen in ‘‘control’’ Sf1-Cre, lox-GFP,
Leprwt/wt mice (Figures 2F, 2G, and 2H), the majority of
pSTAT3-positive neurons in the dmVMH express GFP
(presumed to be SF1-positive neurons). On the other
hand, in ‘‘LEPR-deleted’’ Sf1-Cre, lox-GFP, Leprflox/flox
mice (Figures 2I, 2J, and 2K), pSTAT3 induction in thedmVMH is greatly reduced, and the pSTAT3 that per-
sists is located exclusively in neurons negative for GFP
(presumed to be SF1-negative neurons). As in the
dmVMH, persistent pSTAT3 in the cVMH of ‘‘LEPR-
deleted’’ Sf1-Cre, lox-GFP, Leprflox/flox mice was also
found to be located exclusively in neurons negative for
GFP (presumed to be SF1-negative neurons) (data not
shown). These findings suggest that persistent pSTAT3
activity in Sf1-Cre, lox-GFP Leprflox/flox mice is the result
of leptin action on SF1-negative neurons. This interpre-
tation of LEPRs being present on both SF1-positive and
SF1-negative neurons in the VMH is strongly supported
by our electrophysiological data (next section and
Figure 3D), which demonstrate that most GFP-positive
neurons (presumed to be SF1 positive) are activated
by leptin (and never inhibited by leptin), whereas a signif-
icant proportion of GFP-negative neurons (presumed to
be SF1 negative) are inhibited by leptin (32%).
Leptin Depolarizes and Increases the Firing Rate
of SF1 Neurons
It has previously been shown in the ARC, that leptin ac-
tivates POMC/CART neurons (depolarizes membrane
potential and increases firing rate) and inhibits AGRP/
Leptin Activation of SF1 Neurons in the VMH
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decreases firing rate) (Cowley et al., 2001; van den Top
et al., 2004). To assess the effects of leptin on SF1 neu-
rons, we performed electrophysiologic recordings in the
context of brain slices on GFP-labeled SF1 neurons from
the dorsomedial subdivision of the VMH (dmVMH) of
Sf1-Cre, lox-GFP, Leprwt/wt mice. These GFP-labeled
SF1 neurons are henceforth referred to as ‘‘SF1-posi-
tive’’ neurons. In whole-cell recordings from these neu-
rons, we observed a resting membrane potential of
240 to 250 mV along with frequent and spontaneous
action potentials. These SF1-positive neurons displayed
membrane depolarization and increased frequency of
action potentials in the presence of leptin (representa-
tive tracing shown in Figure 3A). This response was ob-
served in 14 of 17 SF1-positive neurons. We compared
the leptin responsiveness of SF1-positive neurons to
that of POMC-positive neurons from POMC-GFP trans-
genic mice generated in our laboratory. We found that
the responses of SF1-positive neurons to leptin were
similar to those of POMC-positive neurons, i.e., both
types of neurons were depolarized, and both had an in-
creased firing rate when exposed to leptin (data for
POMC-positive neurons not shown). Thus, leptin acti-
vates both SF1-positive and POMC-positive neurons in
the hypothalamus.
We next assessed the electrophysiologic properties
of SF1 neurons lacking LEPRs from Sf1-Cre, lox-GFP,
Leprflox/flox mice. Basal activity of these neurons was
similar to that of SF1-positive neurons of control mice
(resting membrane potential: 247.7 6 1.4 mV, Sf1-Cre,
lox-GFP, Leprwt/wt versus 249.6 6 1.3 mV Sf1-Cre,
lox-GFP, Leprflox/flox; basal firing rate: 0.52 6 0.09 Hz,
Sf1-Cre, lox-GFP, Leprwt/wt versus 0.45 6 0.06 Hz, Sf1-
Cre, lox-GFP, Leprflox/flox). In contrast to SF1-positive
neurons from control mice, leptin had no effect on either
membrane potential or firing rate of SF1 neurons from
Sf1-Cre, lox-GFP, Leprflox/flox mice (Figure 3B). In order
to ensure that these neurons were viable, glutamate,
an excitatory neurotransmitter, was applied to SF1-pos-
itive neurons of Sf1-Cre, lox-GFP, Leprflox/flox mice. In all
cases, glutamate depolarized and increased the firing
rate of these SF1 neurons lacking LEPRs (data not
shown). Leptin’s effects on electrophysiologic proper-
ties of SF1 neurons with or without LEPRs are summa-
rized in Figure 3C. Leptin depolarized (6.1 6 1.0 mV)
and increased the firing rate (2.12-fold 6 0.26-fold) of
SF1 neurons in Sf1-Cre, lox-GFP, Leprwt/wt mice. These
responses were not observed in SF1 neurons from Sf1-
Cre, lox-GFP, Leprflox/flox mice, suggesting that SF1 neu-
rons in the VMH are activated by leptin and that this ac-
tivation is direct because it does not occur when LEPRs
are deleted from SF1 neurons.
We next determined if neurons in the VMH, both SF1-
positive and SF1-negative neurons, respond homoge-
neously to leptin. To accomplish this, using the same
protocol as for SF1-positive neurons, we recorded
from SF1-negative (i.e., GFP-negative) neurons in the
same dorsomedial subdivision of the VMH (dmVMH) of
Sf1-Cre, lox-GFP, Leprwt/wt mice and compared these
responses to those obtained from SF1-positive neurons.
The SF1-negative neurons chosen for recording were
those located in close proximity to SF1-positive neu-
rons. In results summarized in Figure 3D, we observedthat 56% of SF1-negative neurons were unresponsive
to leptin (compare with 18% of SF1-positive neurons),
12% were activated by leptin (compare with 82% of
SF1-positive neurons), and 32% were inhibited by leptin
(compare with 0% of SF1-positive neurons). A represen-
tative trace showing inhibition by leptin is shown in
Figure 3E. Thus, as is true for neurons in the ARC, neu-
rons in the VMH are heterogeneous in their responses
to leptin with SF1 neurons being activated by leptin
and at least one population of SF1-negative neurons be-
ing inhibited by leptin.
Leptin Signaling in SF1 Neurons Is Required
for Normal Energy Homeostasis
To determine the functional importance of LEPRs on
SF1 neurons in body-weight regulation and to compare
their relative importance to that of LEPRs on POMC neu-
rons, we generated mice lacking LEPRs on SF1 neurons
(Sf1-Cre, Leprflox/flox mice) and mice lacking LEPRs on
POMC neurons (Pomc-Cre, Leprflox/flox mice). To rule
out any potential nonspecific effects of the Sf1-Cre
transgene by itself, or the insertion of loxP sites by them-
selves on body weight, we compared the body weights
of Sf1-Cre mice and Leprflox/flox mice to those of wild-
type littermates. The body weights of the three control
groups, i.e., the Sf1-Cre, Leprwt/wt mice, Leprflox/flox
mice and wild-type mice were similar in males
(Figure 4A). Further, two control groups of female
mice, namely Sf1-Cre, Leprwt/wt mice and Leprflox/flox
mice, were also similar (Figure 4B). Thus, neither the
Sf1-Cre transgene nor the lox-modified LEPR allele, by
themselves, have any effect on body weight.
Male and female Sf1-Cre, Leprflox/flox mice had signif-
icantly increased body weights compared to Leprflox/flox
littermate controls (Figures 4A and 4B). At 20 weeks of
age, Sf1-Cre, Leprflox/flox mice had a 15% increase in
body weight over that seen in Leprflox/flox mice. This in-
crease in body weight in Sf1-Cre, Leprflox/flox mice was
similar to that observed in Pomc-Cre, Leprflox/flox mice
(Figures 4A and 4B). The degree of obesity is approxi-
mately 20% of that seen in LeprD/D mice (on a similar ge-
netic background), which have complete deletion of
LEPRs in all neurons (Balthasar et al., 2004; McMinn
et al., 2004). To ensure that the obese phenotype in
Sf1-Cre, Leprflox/flox mice is specific to the loss of LEPRs
on SF1 neurons and is unrelated to any effect caused by
transgene insertion, we crossed a second line ofSf1-Cre
mice (line 7) with Leprflox/flox mice. A similar increase in
body weight was observed in this second line of Sf1-
Cre, Leprflox/flox mice (Figure 4C). Thus, we conclude
that LEPRs on SF1 neurons are required for normal
body weight homeostasis and that leptin action on these
neurons functions to restrain body weight gain.
To determine whether deficiency of LEPRs on these
two sites (SF1 and POMC neurons) has nonadditive, ad-
ditive, or synergistic effects on body weight gain, we fur-
ther generated mice lacking LEPRs on both SF1 and
POMC neurons (Sf1-Cre, Pomc-Cre, Leprflox/flox mice).
These mice were generated by crossing Sf1-Cre,
Leprflox/flox with Pomc-Cre, Leprflox/flox mice. Littermates
resulting from these crosses were used in studies de-
scribed here. The double null mice, i.e., the Sf1-Cre,
Pomc-Cre, Leprflox/flox mice, weighed significantly
more than either of the single-transgenic Leprflox/flox
Neuron
196Figure 4. Effect of SF1 Neuron-Specific Dele-
tion of LEPR on Body Weight
(A) Body weight from male mice, SF1-Cre
(line 2).
(B) Body weight from female mice, SF1-Cre
(line 2).
(C) Body weight from male mice, SF1-Cre
(line 7) (data are represented as mean 6
SEM, n = 10–12 per group).mice. Loss of LEPRs on both SF1 and POMC neurons re-
sulted in an additive effect on body weight (Figures 4A
and 4B). The increased body weight with SF1 neuron-,
POMC neuron-, or both SF1 and POMC neuron-specific
deletion of LEPRS was not associated with any measur-
able increase in food intake (data not shown). This sug-
gests that food intake is unaffected, or alternatively, that
the effect is too small to be detected by the methods
employed in this study.
Loss of Leptin Signaling in SF1 Neurons Results
in Increased Fat Stores
To understand the effects of leptin receptor deletion in
SF1 neurons on body composition, we performed
dual-energy X-ray absorptiometry (DEXA) at 20 weeks
of age. We also dissected and weighed individual fat
pads in Leprflox/flox and Sf1-Cre, Leprflox/flox mice. Asshown in Figures 5A and 5B, Sf1-Cre, Leprflox/flox mice
have an increase in fat mass. We did not observe any dif-
ference in lean mass across groups (data not shown).
Dissection of three distinct fat pads (perigonadal, perire-
nal, and mesenteric) confirmed that the size of these in-
dividual fat stores had been increased in comparison to
Leprflox/flox control mice. The degree of adiposity in Sf1-
Cre, Leprflox/flox mice and Pomc-Cre, Leprflox/flox mice
were roughly similar. Consistent with the increased
weight of the fat pads, serum leptin levels were also in-
creased (Figure 5C).
Sf1-Cre, Leprflox/flox Mice Have Normal Bone Mass
LEPRs in the VMH have previously been implicated in
regulation of bone metabolism by leptin (Takeda et al.,
2002). Thus, we assessed various bone parameters in
Sf1-Cre, Leprflox/flox mice. We did not observe any
Leptin Activation of SF1 Neurons in the VMH
197Figure 5. Effect of SF1 Neuron-Specific Deletion of LEPR on Fat Stores and Serum Leptin
(A) Fat pad weight.
(B) Body fat composition by DEXA analysis.
(C) Serum leptin levels. All data are represented as mean 6 SEM, male mice, 20 weeks of age, n = 5–8 per group. Asterisk = p < 0.05 versus
Leprflox/flox controls; double asterisk = p < 0.01 versus Leprflox/flox controls; triple asterisk = p < 0.001 versus Leprflox/flox controls.difference in either bone density, bone mineral content,
total bone area, femur length, or whole-body length in
mice lacking LEPRs on SF1 neurons or in mice lacking
LEPRs on both SF1 and POMC neurons (Table 1). This
indicates that neither SF1 neurons nor POMC neurons
are involved in mediating the actions of leptin on bone
mass.
Adrenal, Gonadal, and Gonadotroph Function
Is Normal in Sf1-Cre, Leprflox/flox Mice
In addition to the VMH, SF1 is expressed in the adrenal
cortex, gonads, and gonadotrophs of the anterior pitui-
tary (Stallings et al., 2002). To determine if gonadal or
gonadotroph functions were adversely affected in Sf1-
Cre, Leprflox/flox mice, we systematically assessed fertil-
ity in male as well as in female mice. Male and female
mice were housed together over extended periods as
breeding pairs, with one member of the pair having the
genotype of Sf1-Cre, Leprflox/flox and the other member
having the genotype of Leprflox/flox. The average time
between litters was 22.28 6 1.2 days for male Sf1-Cre,
Leprflox/flox mice and 22.00 6 1.2 days for female Sf1-
Cre, Leprflox/flox mice. Because the gestation period for
mice is 21 days, this indicates that male and female
Sf1-Cre, Leprflox/flox mice are able to produce pregnancy
without any delay. Thus, their fertility is unimpaired. Wealso assessed seminal vesicle weights (an indicator of
testosterone levels) in male Sf1-Cre, Leprflox/flox mice
and found no differences from control mice (Table 1).
Thus, the body weight phenotype observed in Sf1-Cre,
Leprflox/flox mice is unlikely to be due to any abnormality
in gonadal steroid function.
To assess the function of the hypothalamic-pituitary-
adrenal axis (HPA axis), we measured serum corticoste-
rone levels at two time points in Leprflox/flox mice and
Sf1-Cre, Leprflox/flox mice. Corticosterone levels in Sf1-
Cre, Leprflox/flox mice exhibited normal diurnal variations
and were not different from those observed in control
mice (Table 1). These findings indicate that adrenal, go-
nadal, and gonadotroph function is unimpaired in Sf1-
Cre, Leprflox/flox mice. Therefore, the observed effects
on body weight are due to deficiency of LEPRs on SF1
neurons in the VMH.
Leptin Signaling in SF1 Neurons Mediates
Resistance to Diet-Induced Obesity
Rodents fed a high-fat diet become hyperleptinemic and
modestly obese. To test the hypothesis that leptin ac-
tion on SF1 neurons restrains further weight gain, we
fed mice lacking LEPRs on SF1 neurons a high-fat,
high-sucrose diet (HFD) from 4–20 weeks of age
(Figure 6A). Control mice responded, as expected, byTable 1. Corticosterone Levels, Gonad Weight, Bone Parameters in Male Mice
Parameter Leprflox/flox Sf1-Cre, Leprflox/flox Sf1-Cre, Pomc-Cre, Leprflox/flox
Seminal vesicle weight (g)
5–8 weeks of age
0.1017 6 0.02 0.1083 6 0.015 0.1064 6 0.013
Serum corticosterone
10–12 weeks of age (ng/ml)
16.9 6 4.48 (AM)
109.8 6 17.7 (PM)
11.50 6 3.9 (AM)
114.50 6 10.29 (PM)
16.7 6 7.9 (AM)
–
Bone-mineral density
(20 weeks of age)
0.06152 6 0.001 0.05926 6 0.001 0.06194 6 0.0015
Bone-mineral content
(20 weeks of age)
0.0098 6 0.0003 0.0096 6 0.0002 0.0099 6 0.0003
Total bone area
(20 weeks of age)
0.158 6 0.003 0.162 6 0.002 0.160 6 0.003
Femur length
(20 weeks of age)
15.31 6 0.08 15.43 6 0.08 15.30 6 0.15
Whole-body length (mm) 10.51 6 0.069 10.58 6 0.057 10.98 6 0.025
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(A) Effects of high-fat feeding on male mice lacking LEPRs in SF1 neurons.
(B) Fat pad weights. (Data are represented as mean6 SEM, male mice, 20 weeks of age, n = 6–7 per group, asterisk = p < 0.05 versus chow-fed
Leprflox/flox mice; double asterisk = p < 0.01 versus chow-fed Leprflox/flox mice; triple asterisk = p < 0.001 versus chow-fed Leprflox/flox mice; pound
sign = p < 0.05 versus high-fat-diet [HFD)-fed Leprflox/flox mice; double pound sign = p < 0.01 versus HFD-fed Leprflox/flox mice).gaining weight when fed the high-fat diet. The rate of
weight gain, however, was small and decreased after
sustained high-fat diet feeding. In contrast, Sf1-Cre,
Leprflox/flox mice rapidly gained weight when fed the
high-fat diet and continued to do so throughout the
study period. Furthermore, we observed that the com-
bined effect of lack of LEPRs on SF1 neurons and
high-fat diet feeding had a synergistic effect on body-
weight gain in Sf1-Cre, Leprflox/flox mice. The effect of
high-fat feeding in mice lacking LEPRs on SF1 neurons
was greater than the expected combined effect of either
perturbation alone (Figure 6A). The weight gain by Sf1-
Cre, Leprflox/flox mice was reflected by increases in fat
mass of all fat stores examined (Figure 6B).
To understand the mechanisms underlying the in-
creased weight gain, we performed another study in
which additional cohorts of mice were switched from
chow to high-fat diet at 8 weeks of age. At this age
(8 weeks old), there is an established difference inbody weight between the control mice and the Sf1-
Cre, Leprflox/flox mice and, as mentioned earlier, we are
unable to detect a difference in food intake. When
mice were switched to high-fat diet, both Leprflox/flox
and Sf1-Cre, Leprflox/flox mice responded by increasing
body weight. However, Sf1-Cre, Leprflox/flox mice gained
substantially greater amounts of weight than did control
mice (Figure 7A). When food intake was assessed, we
observed that at the onset of high-fat diet, both control
Leprflox/flox mice and Sf1-Cre, Leprflox/flox mice increased
the amount of food consumed (Figure 7B). However, as
the high-fat diet continued, food intake declined. Of
note, the Sf1-Cre, Leprflox/flox mice did not suppress
food intake to the degree observed in Leprflox/flox control
mice. Thus, Sf1-Cre, Leprflox/flox mice are deficient in
normal adaptation to high-fat-diet feeding, which in-
volves suppression of caloric intake.
Another feature of the adaptation to high-fat diet
in rodents and mammals is an increase in energyFigure 7. Impaired Response to High-Fat-Diet Feeding in Mice Lacking LEPRs in SF1 Neurons
(A) Effects of high-fat feeding on mice lacking LEPRs in SF1 neurons when switched to a high-fat diet (HFD) at 8 weeks of age.
(B) Effect of high-fat feeding on food intake in Sf1-Cre, Leprflox/flox mice. (Data are represented as mean6 SEM, male mice, 20 weeks of age, n =
6–7 per group. Asterisk = p < 0.05 versus Leprflox/flox HFD controls).
(C) Energy expenditure in Sf1-Cre, Leprflox/flox mice on chow and HFD (data are represented as mean 6 SEM male mice, n = 8 per group; triple
asterisk = p < 0.001 versus chow-fed Leprflox/flox; triple dollar sign = p < 0.001 versus HFD-fed Sf1-Cre, Leprflox/flox; asterisk = p < 0.05 versus
chow-fed Sf1-Cre, Leprflox/flox).
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thermogenesis (Lowell and Spiegelman, 2000). To
test whether the increased body weight in Sf1-Cre,
Leprflox/flox mice fed high-fat diet was associated with
defective diet-induced thermogenesis, we assessed en-
ergy expenditure in mice for a period that spanned 3
days before and 3 days after the start of the high-fat
feeding. Our data show that Sf1-Cre, Leprflox/flox mice
are markedly impaired in their ability to activate diet-in-
duced thermogenesis in response to the high-fat diet
(Figure 7C). Thus, diet-induced obesity in Sf1-Cre,
Leprflox/flox mice is caused by failure to adequately sup-
press food intake as well as failure to adequately stimu-
late energy expenditure. Lack of LEPRs on SF1 neurons
impairs two important physiological adaptations to
high-fat diet leading to a marked imbalance in energy
homeostasis.
Discussion
Establishing the Functional Neuroanatomy
of Body-Weight Control
In recent years, a number of proteins have been identi-
fied, such as leptin, the leptin receptor (LEPR), and the
melancortin-4 receptor, that play key roles in the central
regulation of energy homeostasis (Ahima et al., 2000;
Cone, 2005; Cone et al., 2001; Elmquist, 2000; Heisler
et al., 2003). Extensive neuroanatomical and electro-
physiology studies have outlined neurocircuits that are
hypothesized to be important in controlling energy ho-
meostasis (Cone, 2005; Horvath, 2005; Schwartz and
Porte, 2005; Seeley and Schwartz, 1999). The validity
of these models, however, is largely untested, and this
has been a major limitation for the field. To directly
test the physiological significance of these models, we
and others are now using cre/lox-mediated, neuron-
specific gene manipulation. This methodology makes it
possible to selectively perturb specific proposed neuro-
circuits and then assess consequences in awake, unre-
strained mice. Approaches such as this, in conjunction
with neuroanatomical techniques, will provide the
means of establishing functional neurocircuitry respon-
sible for maintaining normal body weight homeostasis.
It is well established that deficiency of leptin or its re-
ceptor, results in positive energy balance with concom-
itant obesity (Maffei et al., 1995; Zhang et al., 1994). Al-
though it is known that the anti-obesity actions of
leptin are mediated by the brain, the precise neural sub-
strate responsible for this is unknown. Neuroanatomical
studies have suggested that the majority of leptin’s anti-
obesity effects are mediated by LEPRs in the arcuate
nucleus of the hypothalamus (Saper et al., 2002;
Schwartz and Porte, 2005; Spiegelman and Flier,
2001). Although the arguments supporting this view
are strong, they are based almost exclusively on indirect
evidence reviewed in the introduction. As a direct test of
the role of LEPRs on POMC neurons in the ARC, we re-
cently generated mice that lack LEPRs on POMC neu-
rons (Balthasar et al., 2004). These mice developed obe-
sity; however, the magnitude of obesity was much less
than that seen in mice lacking LEPRs everywhere, rais-
ing the possibility that LEPRs in other sites of the brain
may also play an important role in controlling body
weight.Functional Importance of Leptin Action on SF1
Neurons in the VMH
One site of particular interest outside the ARC is the ven-
tromedial hypothalamus (VMH). It was recently shown
that steroidogenic factor-1 (SF1) gene knockout mice
have abnormal VMH development and are obese, sug-
gesting that SF1 neurons in the VMH play an important
role in controlling body weight (Balthasar et al., 2004;
Majdic et al., 2002). To directly test the hypothesis that
LEPRs on VMH neurons contribute to the anti-obesity
actions of leptin, we used cre/lox technology to gener-
ate mice lacking LEPRs on SF1 neurons (Sf1-Cre,
Leprflox/flox mice). Of note, SF1 neurons are located ex-
clusively in the VMH (Stallings et al., 2002). Sf1-Cre,
Leprflox/flox mice develop mild obesity, which is similar
in magnitude to mice lacking LEPRs on POMC neurons
(Pomc-Cre, Leprflox/flox mice). Importantly, mice lacking
LEPRs on SF1 neurons are markedly sensitive to high-
fat-diet-induced obesity. Taken together, these results
demonstrate that leptin action on SF1 neurons in the
VMH plays an important role in controlling body weight.
Interestingly, the degree of obesity seen in Sf1-Cre,
Leprflox/flox mice is similar to that seen in Pomc-Cre,
Leprflox/flox mice. Further, mice lacking LEPRs in both
SF1 and POMC neurons have a body-weight phenotype
that is approximately the sum of that observed with loss
of LEPRs in ether neuronal group alone. Of note, the mu-
tant mice investigated in these studies also exhibit in-
creased leptin levels, which in turn would result in reduc-
tion of body weight through leptin-driven circuits that
remain intact. Furthermore, it is also possible that com-
pensatory changes could occur in feeding circuitry, per-
mitting leptin signaling at some other site to bypass loss
of LEPRs on either POMC or SF1 neurons. For these rea-
sons, the relative importance of leptin signaling on
a given population of neurons, as assessed by the de-
gree of obesity observed in mice with POMC- or SF1-
specific deletion of LEPRs, is likely to be an underesti-
mate. Nevertheless, observation of a similar degree of
obesity in the two models (Pomc-Cre, Leprflox/flox mice
and Sf1-Cre, Leprflox/flox mice) suggests that leptin ac-
tion on these two groups of neurons plays a quantita-
tively similar role in regulating body weight. The fact
that mice with combined deficiency of LEPRs on both
SF1 and POMC neurons are less obese than mice lack-
ing LEPRs everywhere indicates that sites other than
these are also important for leptin action in body-weight
regulation. Possibilities include NPY/AGRP neurons in
the ARC or LEPR-positive neurons in the DMH or brain-
stem (Elmquist, 2000). In total, these findings suggest
that the ability of leptin to restrain body weight is distrib-
uted to a number of different sites in the brain.
Leptin Action on SF1 Neurons Promotes Resistance
to Diet-Induced Obesity
It has recently been reported that high-fat feeding
causes leptin resistance in neurons of the ARC but not
in neurons outside of the ARC, including the VMH
(Munzberg et al., 2004). If this were true, then it is pre-
dicted that leptin signaling in ‘‘non-ARC’’ sites would
play an increasingly important role in restraining further
weight gain during high-fat feeding. In our studies, we
observed that the combined effects of LEPR deficiency
on SF1 neurons and high-fat feeding are greater than
Neuron
200expected from the individual components added to-
gether. The magnitude of obesity seen in Sf1-Cre,
Leprflox/flox mice fed a high-fat diet is far greater than
that seen in wild-type mice. This synergistic interaction
strongly suggests that leptin action on SF1 neurons
plays a particularly important role in resisting high-
fat-diet-induced obesity. Of note, high-fat feeding of
wild-type mice resulted in suppression of appetite and
stimulation of energy expenditure. These adaptive re-
sponses were impaired in Sf1-Cre, Leprflox/flox mice.
Based upon these findings, we hypothesize that during
high-fat feeding, increased leptin levels feed back on
SF1 neurons, suppressing appetite and increasing en-
ergy expenditure, thus restricting further weight gain.
Leptin’s Mechanism of Action in SF1 Neurons
The leptin-mediated, anti-obesity actions of SF1 neu-
rons could be the result of long-term effects on gene ex-
pression secondary to activation of STAT3, rapid effects
on membrane potential and firing rates with augmented
release of neurotransmitters and/or neuropeptides, or
the combined effects of both. Regarding the acute ef-
fects of leptin on membrane potential, we observed
that acute addition of leptin to hypothalamic slices rap-
idly depolarized and increased the firing rate of SF1 neu-
rons (82% activated by leptin, 0% inhibited by leptin,
and 18% unresponsive to leptin). This effect was direct,
i.e., mediated by LEPRs on SF1 neurons because it was
absent in mice lacking LEPRs on these same neurons.
Thus, SF1 neurons are similar to POMC neurons in that
they are both activated by leptin and are distinguished
from AGRP/NPY neurons in the ARC, which are inhibited
by leptin (Cowley et al., 2001; van den Top et al., 2004).
Of note, this activation response in SF1 neurons is not
a general characteristic of VMH neurons but instead, is
a relatively unique response of SF1-expressing cells.
SF1-negative VMH neurons, by comparison, are hetero-
geneous in their response to leptin (12% activated by
leptin, 32% inhibited by leptin, and 56% unresponsive
to leptin).
The relevant anti-obesity signal emanating from SF1
neurons is presently unknown. Recent studies have
raised the possibility of an important role for BDNF in
the VMH (Xu et al., 2003). We suspect that BDNF is not
the relevant mediator in SF1 neurons because mice
lacking BDNF in SF1 neurons (Sf1-Cre, Bdnfflox/flox
mice) failed to develop obesity (data not shown). This,
of course, does not rule out a possible role for BDNF
in ‘‘SF1-negative’’ neurons in the VMH, some of which
may respond directly to leptin. Another candidate medi-
ator, which could play an important role in SF1 neurons,
is the excitatory neurotransmitter, glutamate. Based
upon the heavy expression of VGLUT2 (glutamate syn-
aptic vesicle transport protein) in the VMH and the rela-
tive absence of other neurotransmitter synaptic vesicle
transport proteins in the VMH (Collin et al., 2003; Ziegler
et al., 2002), it is likely that the majority of VMH neurons
are glutamatergic. Of relevance, by using laser scanning
photostimulation, it was recently shown that POMC neu-
rons in the arcuate nucleus receive strong excitatory in-
put from the medial VMH, a region likely to express SF1
(Sternson et al., 2005). To evaluate the anti-obesity role
of glutamate release from SF1 neurons, we are presently
generating mice that lack VGLUT2 in SF1 neurons (Sf1-Cre, vGlut2flox/flox mice). SF1 neurons from these mice
will be unable to release glutamate.
In summary, this study demonstrates that SF1 neu-
rons in the VMH are first-order, leptin-responsive neu-
rons that mediate important anti-obesity effects of lep-
tin. We argue that current models of leptin action will
need to include an important role for SF1 neurons in
the VMH, in addition to neurons in the arcuate nucleus.
SF1 neurons are directly activated by leptin and this
plays a particularly important role in resisting diet-in-
duced obesity. Future work will be required to identify
the relevant signaling factors released by SF1 neurons
(glutamate versus neuropeptides) as well as the down-
stream neurons whose activity is controlled by leptin ac-
tion on SF1 neurons.
Experimental Procedures
Animal Care
Care of all animals and procedures were approved by the Beth Israel
Deaconess Medical Center Institutional animal care and use com-
mittee. Mice were housed at 22ºC–24ºC with a 14 hr light/10 hr
dark cycle with standard mouse chow (Teklad F6 Rodent Diet
8664, 4.05 kcal/g, 3.3 kcal/g metabolizable energy, 12.5% kcal
from fat, Harlan Teklad, Madison, WI) and water provided ad libitum.
Body weight was measured once a week. HFD male mice were
housed individually for all food intake measurements. All diets
were provided as pellets, and chow was weighed once every 7
days. High-fat, high-sucrose diet (Research Diets, D-12331, 58%
kcal from fat, 26% from sucrose, 5.557 kcal/gm) was refilled and
weighed twice per week in order to reduce spillage. Mice were eu-
thanized by CO2 narcosis. Blood was obtained by cardiac puncture,
and tissues were collected and stored at 280ºC until used for
analysis.
Generation of Sf1-Cre BAC Transgenic Mice
SF1-CreBAC transgenic mice were generated by engineering a BAC
genomic clone containing Sf1 and inserting the Cre recombinase se-
quence into the translational site of SF1. For details see Supplemen-
tal Data section.
Generation of Sf1-Cre, Leprflox/flox and Sf1-Cre, Pomc-Cre,
Leprflox/flox Mice
Sf1-Cre mice were mated with Leprflox/flox (129-C57Bl6/J FVB N2)
mice (supplied by S. Chua, Jr., Columbia University, New York),
and a breeding colony was maintained by mating Leprflox/wt and
Sf1-Cre, Leprflox/wt mice. Only littermates were used as study sub-
jects. Leprflox/flox animals were genotyped by PCR with primers
spanning the loxP site: 50-AAT GAA AAA GTT GTT TTG GGA CGA-
30, and 50-CAG GCT TGA GAA CAT GAA CAC AAC AAC-30. Sf1-
Cre, Pomc-Cre, Leprflox/flox were generated by mating Sf1-Cre,
Leprflox/flox mice with Pomc-Cre, Leprflox/flox mice previously gener-
ated in our laboratory. Mice were genotyped for Pomc-Cre as de-
scribed earlier (Balthasar et al. 2004). Pomc-Cre, Leprflox/flox mice
used in studies described in this paper were generated from the
above described cross.
Electrophysiological Studies
Slice Preparation
Young adult mice (4–7 weeks old) were deeply anesthetized with Iso-
flurane prior to decapitation and removal of the entire brain, as pre-
viously described (Cowley et al., 2001; van den Top et al., 2004).
Briefly, brains were removed and immediately submerged in ice-
cold, carbogen-saturated (95% O2 / 5% CO2) aCSF (in mM: 2.5
NaCl, 126 KCl, 1.2 MgCl2, 2.4 CaCl2, 1.2 NaH2PO4, 21.4 NaHCO3,
11.1 glucose). A brain block containing the hypothalamus was
made. Coronal sections (200 mM) were cut with a Leica VT1000S
Vibratome and then incubated in oxygenated aCSF at room temper-
ature for at least 1 hr before recording.
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Slices were transferred to the recording chamber and allowed to
equilibrate for 10–20 min prior to recording. The slices were bathed
in oxygenated aCSF heated to approximately 34ºC at a flow rate of
approximately 2 ml/min. Under ultraviolet (450–480 nm) excitation,
SF-1 neurons were clearly distinguished from adjacent, nonfluores-
cent neurons with an Axioskop FS2 Plus microscope (Zeiss) equip-
ped with a fixed stage and a C2741-60 CCD camera (Hamamatsu).
Whole-cell recordings were then made on identified neurons under
IR-DIC optics by using a MultiClamp 700B Amplifier (Axon Instru-
ment) with the software pClamp 9.0 (Axon Instrument). Recording
electrodes had resistances of 2.5–4 MUwhen filled with the K-gluco-
nate internal solution, which contained (in mM) K-gluconate 128,
HEPEs 10, EGTA 1, KCl 10, MgCl2 1, CaCl2 0.3, Mg-ATP 5, and Na-
GTP 0.3 (pH 7.35 with KOH). Leptin or other agents were applied
to bath solution through perfusion. After acquisition of stable
whole-cell recording for 2–5 min, aCSF solution containing 100 nM
leptin was perfused for 60 to 150 s. This was followed by plain
aCSF application for 5 to 15 min or until significant recovery in mem-
brane activity was observed. In Figure 3, the bar above the recording
trace indicates the duration of leptin application.
Baseline membrane potential and firing rate recorded by Clampex
9.2 were analyzed with MiniAnalysis Program (Synaptosoft, Inc.). For
each recording, the firing rate (or baseline membrane potential) av-
eraged from every 10 s was taken as one data point, 12 to 18 data
points that represent stable activity levels were taken to calculate
mean and standard deviation before and after application of leptin
respectively. A neuron was considered activated or inhibited if the
change (in membrane potential or firing rate) induced by leptin
was 63 times the standard deviation prior to leptin addition.
Tissue Collection for Histology Studies
Animals were deeply anesthetized with intraperitoneal injection of
chloral hydrate (500 mg/kg for mice) and subsequently perfused
transcardially with diethylpyrocarbonate (DEPC)-treated 0.9%
phosphate buffered saline (PBS) followed by 10% neutral buffered
formalin. Brains were removed, stored in the same fixative for 4–6
hr at 4ºC, immersed in 20% sucrose in DEPC-treated PBS (pH 7.0)
at 4ºC overnight, and cut into 25 mm sections on a freezing micro-
tome coronally into five equal series. The sections were placed at
220ºC in an antifreeze solution (Balthasar et al., 2004; Simmons
et al., 1989) until further histological processing. A single series of
sections per animal was used the histological studies.
Generation of SF1 Riboprobe and SF1 In Situ Hybridization
Histochemistry
An SF1 riboprobe was generated by PCR amplification of a 408 bp
fragment of DNA complementary to a portion of exon 4 of mouse
SF-1 from mouse brain cDNA (Clontech, Palo Alto, CA). This ampli-
con was subcloned into pcR4-TOPO vector (Invitrogen, Carlsbad,
CA), according to the manufacturer’s protocol. The sequences and
directionalities of the inserts were confirmed by DNA sequencing.
To generate an antisense 35S-labeled cRNA probe, the plasmid
was linearized by restriction digestion and then subjected to in vitro
transcription with either T3 or T7 RNA polymerases according to the
manufacturer’s protocol (Ambion, Inc., Austin, TX). Control sense ri-
boprobes were similarly generated.
Single-label in situ hybridization histochemistry (ISHH) was per-
formed as reported previously (Kishi et al., 2003; Marcus et al., 2001).
Data Analysis and Production of Photomicrographs for ISHH
ISHH patterns were visualized first on autoradiographic film and
then by observing slides dipped in photographic emulsion for direct,
cellular visualization. Histological detail was noted by examining ad-
jacent brain sections stained for thionin. Brain sections were viewed
with both a Zeiss Axioskop and a Zeiss Stemi 2000-C dissecting mi-
croscope with both brightfield and darkfield optics. Photomicro-
graphs were produced with a Zeiss digital camera attached to the
microscopes and a Dell desktop computer. Qualitative estimates
of SF1 mRNA expression in specific brain sites were made by con-
sidering both signal strength and the number of labeled cells. An im-
age editing software program, Adobe Photoshop 7.0, was used to
combine the photomicrographs into plates.Single-Label Immunohistochemistry for GFP
IHC was begun after first washing the ISHH-processed sections in
PBS (pH 7.4). Sections were pretreated with 0.3% hydrogen perox-
ide in PBS (pH 7.4) for 30 min at room temperature and then were in-
cubated in 3% normal donkey serum (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA) with 0.25% Triton X-100 in
PBS (PBT-azide) for 2 hr. Next, the slides were incubated overnight
at room temperature in a rabbit anti-GFP primary antiserum (Molec-
ular Probes, Cat # a-6455; 1:20,000 in PBT-azide). After washing in
PBS, sections were incubated in either biotinylated donkey anti-rab-
bit IgG (Jackson ImmunoResearch Laboratories; 1:1,000) for 2 hr at
room temperature, followed by incubation for 1 hr in a solution of av-
idin-biotin complex (Vectastain Elite ABC Kit, Vector Laboratories,
Burlingame, CA; 1:500) diluted in PBS. The sections next were
washed in PBS and incubated in a solution of 0.04% diaminobenzi-
dine tetrahydrochloride (DAB; Sigma) and 0.01% hydrogen peroxide
in PBS. Sections were mounted onto SuperFrost slides and then vi-
sualized with Zeiss Axioskop as described above.
Dual-Label ISHH/Immunohistochemistry for SF1 and GFP
Free-floating sections of mouse brains were processed sequentially
by ISHH and IHC by a protocol reported previously (Elias et al., 1998;
Liu et al., 2003). Two series of different Sf1-Cre, lox-GFP mouse
brains were processed for SF1 coexpression with GFP as described
in the section above. A neuron was considered GFP-positive if the
cell body and nucleus was clearly DAB labeled (orange-brown stain
in Figure 1D). A GFP-positive neuron was considered Sf1 positive if it
was decorated with at least ten silver grains (which is 33 above
background). 1000 GFP-positive VMH neurons were identified and
scored as either SF1 positive or SF1 negative based on the criteria
set forth above.
Single Immunohistochemistry for pSTAT3
Fed male 4–6 week old Leprflox/flox and Sf1-Cre, Leprflox/flox mice
were injected (n = 3 per genotype) intraperitoneally with 100 mg re-
combinant mouse leptin (A.F. Parlow, National Hormone and Pep-
tide Program) or saline and perfused with 10% formalin 45 min later.
Brain tissue was processed as described in section of tissues pro-
cessing for histological studies earlier. p-STAT3 IHC was performed
as described earlier (Munzberg et al., 2003) for further details see
Supplemental Data.
Dual-Label Immunohistochemistry for pSTAT3 and GFP
Single IHCC for pSTAT3 was performed as stated above followed by
IHCC for GFP. For details please see Supplemental Data.
Body and Blood Composition
Ad libitum fed 20 week old mice were anesthetized for dual-energy
X-ray absorptiometry (MEC LunarCorp. Minster, OH). Blood was col-
lected by cardiac puncture. Serum was assayed with a commercially
available kit for leptin (Crystal Chem. Inc., Downers Grove, IL). Mes-
enteric, perigonadal, and perirenal fat pads were harvested from
these mice and weighed. Femur length, bone mineral content,
bone mineral density, and bone area was measured by DEXA. Cor-
ticosterone was measured with a commercially available kit at two
time points in mice 10–12 weeks old (ICN Biomedicals, Inc., Costa
Mesa, CA). Animals were sacrificed within 1 min of handling to obtain
serum used for corticosterone analysis. Seminal vesicle weight was
assessed in another set of animals, male 5–8 weeks of age.
Energy Expenditure
Oxygen consumption was measured by indirect calorimetry. Male
mice, 6–8 weeks of age, were placed at room temperature (22ºC–
24ºC) in chambers in an OXYMAX system (Columbus Instruments,
Columbus, OH) with a settling time of 120 s and a measuring time
of 60 s with room air as the reference. Food and water were provided
ad libitum. Mice were acclimatized in the chambers for 48 hr prior to
data collection. Oxygen consumption was measured for 72 hr on
chow diet followed by 72 hr on HFD in the same set of animals.
Data is presented as average VO2 ml/hr/mouse.
Data Analysis
All values are reported as mean 6 SEM. Data analysis was per-
formed with GraphPad PRISM software (GraphPad, San Diego,
Neuron
202CA). Statistical significance was determined by one-way analysis of
variance or two-tailed unpaired Student’s t tests; p < 0.05 was con-
sidered significant.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/49/2/191/DC1/.
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